Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Star
6483.0000 -55.00 (-0.84%)
NSE May 23, 2025 15:31 PM
Volume: 224.1K
 

6483.00
-0.84%
Phillip Capital
Outlook and valuation: While earnings were higher than we expected, H1 performance is almost in line with our FY16 expectations. Hence, we have maintained our estimates for FY16/17 and continue to value the company at Rs 1045 (22x FY17 earnings), implying 9%...
Divi's Laboratories .. has an average target of 5832.12 from 9 brokers.
More from Divi's Laboratories Ltd.
Recommended